Cargando…

Corrigendum to “HDAC and HMT Inhibitors in Combination with Conventional Therapy: A Novel Treatment Option for Acute Promyelocytic Leukemia”

Detalles Bibliográficos
Autores principales: Vitkevičienė, Aida, Skiauterytė, Giedrė, Žučenka, Andrius, Stoškus, Mindaugas, Gineikienė, Eglė, Borutinskaitė, Veronika, Griškevičius, Laimonas, Navakauskienė, Rūta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7487093/
https://www.ncbi.nlm.nih.gov/pubmed/32952555
http://dx.doi.org/10.1155/2020/1834190
_version_ 1783581421247397888
author Vitkevičienė, Aida
Skiauterytė, Giedrė
Žučenka, Andrius
Stoškus, Mindaugas
Gineikienė, Eglė
Borutinskaitė, Veronika
Griškevičius, Laimonas
Navakauskienė, Rūta
author_facet Vitkevičienė, Aida
Skiauterytė, Giedrė
Žučenka, Andrius
Stoškus, Mindaugas
Gineikienė, Eglė
Borutinskaitė, Veronika
Griškevičius, Laimonas
Navakauskienė, Rūta
author_sort Vitkevičienė, Aida
collection PubMed
description
format Online
Article
Text
id pubmed-7487093
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-74870932020-09-17 Corrigendum to “HDAC and HMT Inhibitors in Combination with Conventional Therapy: A Novel Treatment Option for Acute Promyelocytic Leukemia” Vitkevičienė, Aida Skiauterytė, Giedrė Žučenka, Andrius Stoškus, Mindaugas Gineikienė, Eglė Borutinskaitė, Veronika Griškevičius, Laimonas Navakauskienė, Rūta J Oncol Corrigendum Hindawi 2020-09-04 /pmc/articles/PMC7487093/ /pubmed/32952555 http://dx.doi.org/10.1155/2020/1834190 Text en Copyright © 2020 Aida Vitkevičienė et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Corrigendum
Vitkevičienė, Aida
Skiauterytė, Giedrė
Žučenka, Andrius
Stoškus, Mindaugas
Gineikienė, Eglė
Borutinskaitė, Veronika
Griškevičius, Laimonas
Navakauskienė, Rūta
Corrigendum to “HDAC and HMT Inhibitors in Combination with Conventional Therapy: A Novel Treatment Option for Acute Promyelocytic Leukemia”
title Corrigendum to “HDAC and HMT Inhibitors in Combination with Conventional Therapy: A Novel Treatment Option for Acute Promyelocytic Leukemia”
title_full Corrigendum to “HDAC and HMT Inhibitors in Combination with Conventional Therapy: A Novel Treatment Option for Acute Promyelocytic Leukemia”
title_fullStr Corrigendum to “HDAC and HMT Inhibitors in Combination with Conventional Therapy: A Novel Treatment Option for Acute Promyelocytic Leukemia”
title_full_unstemmed Corrigendum to “HDAC and HMT Inhibitors in Combination with Conventional Therapy: A Novel Treatment Option for Acute Promyelocytic Leukemia”
title_short Corrigendum to “HDAC and HMT Inhibitors in Combination with Conventional Therapy: A Novel Treatment Option for Acute Promyelocytic Leukemia”
title_sort corrigendum to “hdac and hmt inhibitors in combination with conventional therapy: a novel treatment option for acute promyelocytic leukemia”
topic Corrigendum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7487093/
https://www.ncbi.nlm.nih.gov/pubmed/32952555
http://dx.doi.org/10.1155/2020/1834190
work_keys_str_mv AT vitkevicieneaida corrigendumtohdacandhmtinhibitorsincombinationwithconventionaltherapyanoveltreatmentoptionforacutepromyelocyticleukemia
AT skiauterytegiedre corrigendumtohdacandhmtinhibitorsincombinationwithconventionaltherapyanoveltreatmentoptionforacutepromyelocyticleukemia
AT zucenkaandrius corrigendumtohdacandhmtinhibitorsincombinationwithconventionaltherapyanoveltreatmentoptionforacutepromyelocyticleukemia
AT stoskusmindaugas corrigendumtohdacandhmtinhibitorsincombinationwithconventionaltherapyanoveltreatmentoptionforacutepromyelocyticleukemia
AT gineikieneegle corrigendumtohdacandhmtinhibitorsincombinationwithconventionaltherapyanoveltreatmentoptionforacutepromyelocyticleukemia
AT borutinskaiteveronika corrigendumtohdacandhmtinhibitorsincombinationwithconventionaltherapyanoveltreatmentoptionforacutepromyelocyticleukemia
AT griskeviciuslaimonas corrigendumtohdacandhmtinhibitorsincombinationwithconventionaltherapyanoveltreatmentoptionforacutepromyelocyticleukemia
AT navakauskieneruta corrigendumtohdacandhmtinhibitorsincombinationwithconventionaltherapyanoveltreatmentoptionforacutepromyelocyticleukemia